Leveraging Technology has vast management experience in the areas of research & development, new product launches, marketing, product management, technical services, mergers & aquisitions, business start-ups and strategic planning.
Experience Highlights
Fred Fraser, Ph.D.
Start-ups & General Management:
Worked with businesses in the laboratory device, consulting, e-commerce, blood bank screening, and dialysis industries; CEO of medical device start-up.
Technology & Product Licensing:
Negotiated and executed over 20 license agreements.
Market Development:
Developed successful relaunch of stalled HIV test leading to 40% market share in 2 years.
Regulated Product Development:
Worked to develop first monoclonal antibody drug test, first FDA approved HIV confirmatory test (PLA), and first fully integrated clinical chemistry & heterogeneous immunoassay analyzer.
Market Research & Strategic Planning:
Collaborated on projects including surgical devices, wound closure materials, dental materials, instrumented drug delivery systems and multiplex analysis systems.
High Level Selling:
Experienced in selling technology to U.S. and international VIP prospects.
Personnel Development:
Lead numerous, cross-functional work teams and staff groups as large as 75.
Mergers & Acquisitions:
Due diligence leader for $525 million auction sale of DuPont Diagnostics.
Project Management:
20 years experience using PACE and team leader of high profile projects.
Financial Management:
Including royalty income, over 80 license contracts, and a $75 million R&D portfolio including capital expenditures and software; P&L management of $36 million business in blood bank testing.
R&D Leader (contract) for Biomedical Products in Applied Biosciences at the DuPont Company. Reorganized product development pipeline for lower risk revenue horizon. Developing partnerships with medical device companies for a cashless leveraging of business unit for 2009 and 2010.
Guided start-up of engineering and intellectual property company, bioSys Inc., leading to license and joint development agreements for an automated blood tube centrifuge with leading European company. AutoFuge™ prototype is developed, and our partner will introduce AutoFuge™ in July 2009 at the American Association of Clinical Chemistry meeting in Chicago, IL.
Market and technology assessment of medical device opportunities for multiple projects for multiple clients, ranging from pre-qualification of long range research investments to measuring customer needs for specific product concepts to quantitatively defining design inputs for product development. Completed assessments for potential technologies and products for wound closure hydrogels and nonwoven bioadhesives (internal and external), adhesion barriers, hemostatic materials, embolic agents for interventional radiology, ophthalmic liquid bandage, radioactive seed materials, dental materials, immunologic markers for cardiovascular disease, multiplexed biomarker assays, automated histochemistry slide preparation for cancer screening, antimicrobial coatings for implanted devices, and food testing.
Developed detailed technology spin-off plan, business and financial plans, and venture funding plan for start-up business in real-time hemodialysis monitoring and assisted client during start-up phase.
Performed product development process assessment by surveying client’s current process and provided improvement direction for product line strategy, project management, and technology acquisition.
